OptimizeRx Corp Annual Income Tax Expense (Benefit) in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
OptimizeRx Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2024.
  • OptimizeRx Corp Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $2.29M.
  • OptimizeRx Corp Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $725K.
  • OptimizeRx Corp annual Income Tax Expense (Benefit) for 2024 was $725K.
  • OptimizeRx Corp annual Income Tax Expense (Benefit) for 2023 was -$7.6M.
  • OptimizeRx Corp annual Income Tax Expense (Benefit) for 2019 was -$898K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $725K +$8.32M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 -$7.6M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2019 -$898K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2016-03-15
2014 $0 $0 Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 $0 Jan 1, 2013 Dec 31, 2013 10-K 2015-09-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.